title: Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell cultures.
abstract: The plasticity of mature oligodendrocytes was studied in aggregating brain cell cultures at the period of maximal expression of myelin marker proteins. The protein kinase C (PKC)-activating tumor promoters mezerein and phorbol 12-myristate 13-acetate (PMA), but not the inactive phorbol ester analog 4alpha-PMA, caused a pronounced decrease of myelin basic protein (MBP) content and 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNP) activity. In contrast, myelin/oligodendrocyte protein (MOG) content was affected relatively little. Northern blot analyses showed a rapid reduction of MBP and PLP gene expression induced by mezerein, and both morphological and biochemical findings indicate a drastic loss of compact myelin. During the acute phase of demyelination, only a relatively small increase in cell death was perceptible by in situ end labeling and in situ nick translation. Basic fibroblast growth factor (bFGF) also reduced the levels of the oligodendroglial differentiation markers and enhanced the demyelinating effects of the tumor promoters. The present results suggest that PKC activation resulted in severe demyelination and partial loss of the oligodendrocyte-differentiated phenotype.
authors.affiliation: Institut de Physiologie, Université de Lausanne, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Pouly
authors.forename: M K
authors.initials: MK
authors.lastname: Storch
authors.forename: J M
authors.initials: JM
authors.lastname: Matthieu
authors.forename: H
authors.initials: H
authors.lastname: Lassmann
authors.forename: F
authors.initials: F
authors.lastname: Monnet-Tschudi
authors.forename: P
authors.initials: P
authors.lastname: Honegger
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000737:chemistry; D001921:Brain / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D002273:Carcinogens / Q000633:toxicity*; D002449:Cell Aggregation / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D003711:Demyelinating Diseases / Q000139:chemically induced / Q000201:enzymology* / Q000473:pathology; D004224:Diterpenes; D004789:Enzyme Activation; D016222:Fibroblast Growth Factor 2 / Q000633:toxicity; D015870:Gene Expression; D009185:Myelin Proteins / Q000235:genetics / Q000378:metabolism; D009836:Oligodendroglia / Q000187:drug effects*; D011493:Protein Kinase C / Q000378:metabolism*; D051381:Rats; D013729:Terpenes / Q000633:toxicity; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity
chemical_list: D015415:Biomarkers; D002273:Carcinogens; D004224:Diterpenes; D009185:Myelin Proteins; D013729:Terpenes; D016222:Fibroblast Growth Factor 2; C011309:mezerein; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate